Patients of neurological conditions such as stroke, multiple sclerosis, and Parkinson's disease will now be able to more easily access an innovative, next-generation therapy, with brain-computer interface (BCI) recoveriX now available in hospitals and neurorehabilitation centers in various countries worldwide.
recoveriX, which was first developed by Austria-based g.tec medical engineering GmbH, uses BCI technology to stimulate muscles, helping restore function in the patient's limbs after being impaired by neurological conditions. Using recoveriX improves neuroplasticity, which helps rewire nervous pathways and replace damaged neurons that were affected by the stroke, multiple sclerosis, or Parkinson's disease.
